$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000838 Size: 6 KB 网页链接
$Recro制药(REPH)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001192482-20-000834 Size: 5 KB 网页链接
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000809 Size: 4 KB 网页链接
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000808 Size: 5 KB 网页链接
$Recro制药(REPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-052177 Act: 34 Size: 8 MB 网页链接
$Recro制药(REPH)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001564590-20-052174 Act: 34 Size: 1 MB 网页链接
$Recro制药(REPH)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-20-250613 Act: 34 Size: 7 MB 网页链接
$Recro制药(REPH)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-20-214135 Act: 33 Size: 465 KB 网页链接
$Recro制药(REPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-038590 Act: 34 Size: 8 MB 网页链接
$Recro制药(REPH)$ 8-K Current report, items 2.02, 7.01, 8.01, and 9.01 Accession Number: 0001193125-20-214072 Act: 34 Size: 9 MB 网页链接